Background The influence of different crystalloid solutions infused during deceased-donor
kidney transplant on the incidence of delayed graft function remains unclear. We …

Intravenous fluid therapy is the most commonly prescribed inpatient medication in hospitals
around the world. Intravenous fluids are drugs and have an indication, a dose, and expected …

United States will have endstage renal disease. 1 Kidney transplantation is a critically
important intervention for these individuals: transplantation improves survival, quality of life …

BACKGROUND: Insufficient fluid administration intra-and postoperatively may lead to
delayed renal graft function (DGF), while fluid overload increases the risk of heart failure …

Delayed graft function (DGF) after deceased donor kidney transplantation, defined clinically
as the need for at least one dialysis session within the first week after transplantation, is a …

Purpose Planning intraoperative fluid therapy in patients undergoing major abdominal
surgery is important. It was aimed to define the difference between fluid therapy protocols for …

Perioperative acute kidney injury (AKI) occurrence is probably increased in recent years due
to the increased level of complexity of surgical procedures and severity of illness of surgical …

Kidney transplantation is now recognized as the treatment of choice for patients with chronic
renal failure. Despite the extension of indications to patients suffering severe hypertension …

Objective To explore the effects of fluid therapy with the synthetic colloids hydroxyethyl
starch (HES) and gelatin (GEL) on the incidence of acute kidney injury (AKI) and need for …

Background Delayed graft function, the requirement for dialysis due to poor kidney function
post-transplant, is a frequent complication of deceased donor kidney transplantation and is …